Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081738 | SCV000113673 | benign | not specified | 2015-10-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000081738 | SCV000170316 | benign | not specified | 2013-05-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000081738 | SCV000312560 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000264092 | SCV000357921 | benign | Disorders of Intracellular Cobalamin Metabolism | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589848 | SCV000699395 | benign | not provided | 2016-01-25 | criteria provided, single submitter | clinical testing | Variant summary: The c.321G>A in MMACHC gene is a synonymous change that involves a non-conserved nucleotide. 3/5 programs in Alamut predict that this variant does not affect normal splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in the control population dataset of ExAC at an overall frequency of 47%, suggesting it is a common polymorphism. The variant has been reported as Benign by several reputable databases/clinical laboratories. Taken together, this variant has been classified as Benign. |
Labcorp Genetics |
RCV001513687 | SCV001721346 | benign | Cobalamin C disease | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001513687 | SCV001750442 | benign | Cobalamin C disease | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000589848 | SCV005284441 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000081738 | SCV001742517 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000081738 | SCV001920516 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000081738 | SCV001955967 | benign | not specified | no assertion criteria provided | clinical testing |